Table 1.
Characteristics of Parkinson's disease patients that underwent MRgFUS treatment.
| Authors & year | Target | Patients, n | Age, y (range) |
Sex, m | Tremor dominant | Levodopa treatment | Disease duration, y (range) |
|---|---|---|---|---|---|---|---|
| Magara et al. 2014 | Pallidothalamic tract | 13 | 64.5 (37–82) |
8 | 9 | 11 | 9.7 (3–27) |
| Schlesinger et al. 2015 | Thalamotomy | 7 | 59 (46–74) |
6 | 7 | 3 | 5.4 (2.5–10) |
| Na et al. 2015 | Pallidotomy | 1 | 56 | 0 | 0 | 1 | 12 |
| Zaaroor et al. 2017 | Thalamotomy | 12∗ | 62.8 (46–75) |
11 | 12 | 5 | 7.1 (2–16) |
∗Of the 12 patients in Zaaroor et al., 7 are the same patients as in Schlesinger et al.